SNCA 抗体
(Synuclein, alpha (SNCA))
Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Four alternatively spliced transcripts encoding two different isoforms have been identified for this gene. [provided by RefSeq, Mar 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| SNCA 抗体 (pSer129) | 人, 小鼠, 大鼠, Cow, 猴, Pig, 犬, 兔, 马 | 兔 Polyclonal |
|
|
|
| SNCA 抗体 (Glu123) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SNCA 抗体 (Asp119) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SNCA 抗体 (Met127) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SNCA 抗体 (AA 70-119) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| Recombinant SNCA 抗体 | 人 | 兔 Monoclonal |
|
|
|
| Recombinant SNCA 抗体 | 人 | 兔 Monoclonal |
|
|
|
| Rockland Original | SNCA 抗体 | 人 | 小鼠 Monoclonal |
|
|
| SNCA 抗体 (C-Term, Intracellular) | 大鼠 | 豚鼠 Polyclonal |
|
|
|
| SNCA 抗体 (pTyr125) | 人, 小鼠, 大鼠, Cow, 猴, Pig | 兔 Polyclonal |
|
|
|
| SNCA 抗体 | 人, 大鼠, Cow, Pig | 小鸡 Polyclonal |
|
|
|
| SNCA 抗体 | 人, 大鼠, Cow, Pig | 小鼠 Monoclonal |
|
|
|
| SNCA 抗体 | 人, Rodents | 小鼠 Monoclonal |
|
|
|
| SNCA 抗体 (truncated) | 人 | 小鼠 Monoclonal |
|
|
|
| SNCA 抗体 (Middle Region) | 人, 小鼠, 大鼠, Cow, 绵羊, 犬, 兔, 马, 豚鼠 | 兔 Polyclonal |
|
|
|
| SNCA 抗体 (pSer129) | 人, 小鼠, 大鼠 | 兔 Monoclonal |
|
|
|
| SNCA 抗体 (pSer129) | 人 | 兔 Monoclonal |
|
|
|
| SNCA 抗体 | 人, 小鼠, 大鼠 | 兔 Monoclonal |
|
|
|
| Rockland Original | SNCA 抗体 (pSer129) | 大鼠 | 兔 Polyclonal |
|
|
| SNCA 抗体 (C-Term, Intracellular) | 大鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠, 大鼠, Cow, 猴, Pig, 犬, 兔, 马
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer129
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Glu123
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Asp119
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Met127
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 70-119
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 10000001000000
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- R01-4E1
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- FM (Fluorescence Microscopy: 所列应用)
- MA (Multiplex Assay: 所列应用)
- Supplier Product No.
- Rockland 500-301-e56
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2A7
- 标记
- unconjugated
- 抗体亚型
- IgG1
Rockland Original
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 大鼠
- 宿主
- 豚鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 97-110, C-Term, Intracellular
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, Cow, 猴, Pig
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- pTyr125
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 大鼠, Cow, Pig
- 宿主
- 小鸡
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgY
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 大鼠, Cow, Pig
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3H9
- 标记
- unconjugated
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, Rodents
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2A7
- 标记
- unconjugated
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2B2D1-2B2A11
- 标记
- unconjugated
- 抗原表位
- truncated
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, Cow, 绵羊, 犬, 兔, 马, 豚鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- CDC-19
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer129
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- BBF-19
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer129
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- Supplier Product No.
- Rockland 612-401-c70
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer129
Rockland Original
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 97-110, C-Term, Intracellular
Latest Publications for our SNCA 抗体
: "Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease." in: International journal of pharmaceutics, Vol. 579, pp. 119148, (2020) (PubMed).
: "Neurodegenerative Disease-Related Proteins within the Epidermal Layer of the Human Skin." in: Journal of Alzheimer's disease : JAD, Vol. 69, Issue 2, pp. 463-478, (2019) (PubMed).
: "Rosmarinic acid attenuates inflammatory responses through inhibiting HMGB1/TLR4/NF-κB signaling pathway in a mouse model of Parkinson's disease." in: Life sciences, Vol. 223, pp. 158-165, (2019) (PubMed).
: "An Enriched Environment Ameliorates Oxidative Stress and Olfactory Dysfunction in Parkinson's Disease with α-Synucleinopathy." in: Cell transplantation, Vol. 27, Issue 5, pp. 831-839, (2019) (PubMed).
: "Apelin-36 mitigates MPTP/MPP+-induced neurotoxicity: Involvement of α-synuclein and endoplasmic reticulum stress." in: Brain research, Vol. 1721, pp. 146334, (2019) (PubMed).
: "Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy." in: Translational neurodegeneration, Vol. 8, pp. 24, (2019) (PubMed).
: "Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide." in: Neuron, (2018) (PubMed).
: "Quantitative Proteomics Reveals the Regulatory Networks of Circular RNA CDR1as in Hepatocellular Carcinoma Cells." in: Journal of proteome research, Vol. 16, Issue 10, pp. 3891-3902, (2018) (PubMed).
: "Elevated levels of alpha-synuclein blunt cellular signal transduction downstream of Gq protein-coupled receptors." in: Cellular signalling, Vol. 30, pp. 82-91, (2016) (PubMed).
: "Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA)." in: The Journal of biological chemistry, Vol. 289, Issue 17, pp. 11897-905, (2014) (PubMed).
: "Neurodegenerative Disease-Related Proteins within the Epidermal Layer of the Human Skin." in: Journal of Alzheimer's disease : JAD, Vol. 69, Issue 2, pp. 463-478, (2019) (PubMed).
: "Rosmarinic acid attenuates inflammatory responses through inhibiting HMGB1/TLR4/NF-κB signaling pathway in a mouse model of Parkinson's disease." in: Life sciences, Vol. 223, pp. 158-165, (2019) (PubMed).
: "An Enriched Environment Ameliorates Oxidative Stress and Olfactory Dysfunction in Parkinson's Disease with α-Synucleinopathy." in: Cell transplantation, Vol. 27, Issue 5, pp. 831-839, (2019) (PubMed).
: "Apelin-36 mitigates MPTP/MPP+-induced neurotoxicity: Involvement of α-synuclein and endoplasmic reticulum stress." in: Brain research, Vol. 1721, pp. 146334, (2019) (PubMed).
: "Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy." in: Translational neurodegeneration, Vol. 8, pp. 24, (2019) (PubMed).
: "Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide." in: Neuron, (2018) (PubMed).
: "Quantitative Proteomics Reveals the Regulatory Networks of Circular RNA CDR1as in Hepatocellular Carcinoma Cells." in: Journal of proteome research, Vol. 16, Issue 10, pp. 3891-3902, (2018) (PubMed).
: "Elevated levels of alpha-synuclein blunt cellular signal transduction downstream of Gq protein-coupled receptors." in: Cellular signalling, Vol. 30, pp. 82-91, (2016) (PubMed).
: "Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA)." in: The Journal of biological chemistry, Vol. 289, Issue 17, pp. 11897-905, (2014) (PubMed).
Aliases for SNCA 抗体
synuclein alpha L homeolog (snca.L) 抗体alpha-synuclein (LOC619283) 抗体
synuclein alpha (SNCA) 抗体
synuclein, alpha (Snca) 抗体
synuclein alpha (Snca) 抗体
alphaSYN 抗体
LOC619283 抗体
MGC64356 抗体
NACP 抗体
PARK1 抗体
PARK4 抗体
PD1 抗体
snca 抗体
您还需要查找其他产品吗？
You are here:
